Correction: Combining lenalidomide with IL-2 family of cytokines enhances activating receptor and perforin/granzyme expression in NK cells

Puntos clave

• The primary aim is to investigate the effects of combining lenalidomide with cytokines on NK cell activity.
• Examined the expression levels of activating receptors and perforin/granzyme in NK cells.
• Utilized in vitro assays to assess the impact of the combination treatment on NK cell function.
• Lenalidomide significantly increased activating receptor expression on NK cells compared to control.
• Combined treatment showed enhanced perforin and granzyme expression in NK cells.